Literature DB >> 17312440

Functional derangement and cardiac innervation in the apical ballooning syndrome: a 123I-meta-iodobenzylguanidine scintigraphic and dobutamine stress echocardiographic study.

Antonella Moreo1, Benedetta De Chiara, Mario Possa, Roberto Sara, Irene Bossi, Pedro Silva Orrego, Elisa Nicolosi, Francesco Mauri, Oberdan Parodi.   

Abstract

Several cases of transient left ventricular apical ballooning syndrome have already been described, but the pathophysiological mechanisms of this syndrome still remain unclear. We report the case of a patient evaluated in the acute phase of apical ballooning by coronary angiography and echocardiography who was submitted to I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy and dobutamine stress echocardiography one month after the discharge. MIBG scintigraphy demonstrated a decreased tracer uptake in the apical and periapical anterior regions, whilst myocardial perfusion at rest was normal. Dobutamine induced an increased left ventricular outflow tract gradient and hypokinesis in the apical and periapical segments, mimicking the findings that occurred in the acute phase, and in agreement with the location of MIBG abnormalities. After a two-month treatment with carvedilol, MIBG uptake increased in the apical and periapical anterior regions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17312440     DOI: 10.2459/01.JCM.0000260843.76156.84

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  2 in total

1.  Selective Serotonin-norepinephrine Reuptake Inhibitors-induced Takotsubo Cardiomyopathy.

Authors:  Rahul Vasudev; Upamanyu Rampal; Hiten Patel; Kunal Patel; Mahesh Bikkina; Fayez Shamoon
Journal:  N Am J Med Sci       Date:  2016-07

2.  Persisting myocardial sympathetic dysfunction in takotsubo cardiomyopathy.

Authors:  Hein J Verberne; Dirk J van der Heijden; Berthe L F van Eck-Smit; G Aernout Somsen
Journal:  J Nucl Cardiol       Date:  2009-01-22       Impact factor: 5.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.